Navigation Links
Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference
Date:10/31/2007

new">http://www.amarincorp.com. Information on our website does not form part of this press release.

Disclosure Notice:

The information contained in this document is as of October 31, 2007. Amarin assumes no obligation to update any forward-looking statements contained in this document as a result of new information or future events or developments. This document contains forward-looking statements about Amarin's financial condition, results of operations, business prospects and products in research that involve substantial risks and uncertainties. You can identify these statements by the fact that they use words such as "will", "anticipate", "estimate", "expect", "project", "forecast", "intend", "plan", "believe" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or events. Among the factors that could cause actual results to differ materially from those described or projected herein are the following: risks relating to the Company's ability to maintain its Nasdaq listing (including the risk that the Company may not be able to achieve compliance with the Nasdaq minimum bid price and/or other continued listing criteria within the required timeframe or at all and the risk that the Company may not be able to successfully appeal a Nasdaq delisting determination); the success of Amarin's research and development activities; decisions by regulatory authorities regarding whether and when to approve Amarin's drug applications, as well as their decisions regarding labeling and other matters that could affect the commercial potential of Amarin's products; the speed with which regulatory authorizations, pricing approvals and product launches may be achieved; the success with which developed products may be commercialized; competitive developments affecting Amarin's products under development; the effect of possible domestic and foreign legislation or regulatory action affecting, among oth
'/>"/>

SOURCE Amarin Corporation Plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
11. Wisconsin firms to present at Cleantech venture capital event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... WEST PALM BEACH, Fla. , July 11, 2014 ... wide variety of high-quality peptides that are used solely ... online. To honor two successful years in business, Maxim ... Performance LLC, has just launched a new and updated ... addition, the research blog section has been updated with ...
(Date:7/11/2014)... - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today announced that ... use as a once-daily adjunctive therapy for the treatment ... not satisfactorily controlled with conventional therapy.  APTIOM TM ... years of age. Epilepsy is one ... Epilepsy Canada, it affects 0.6% of the population and ...
(Date:7/10/2014)... 10, 2014 Deep Knowledge Ventures ... Forum on ‘Commercialising Longevity Research’ and welcomed a ... the London Bioscience Innovation Center for the event, ... Aging Analytics Ltd. The meeting highlighted the need ... research for age-related disease, as well as the ...
(Date:7/10/2014)... 2014 OMICS Group’s 5th International conference ... August, 2014 at Double Tree by Hilton Beijing, China ... in Analytical & Bioanalytical research methods only to facilitate ... this occasion, Dr. Srinubabu Gedela, MD of OMICS Group ... a remarkable one in bringing a unique and international ...
Breaking Biology Technology:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4
... MRIGlobal, an internationally recognized research and development organization ... has appointed Richard A. Winegar, Ph.D., to Principal Advisor ... Dr. Winegar is a recognized expert in ... genetic toxicology.  As Principal Advisor for Science, he will ...
... July 11, 2011 Avisena, one of the nation,s ... for physician practices, today announced the extension of a ... facility will be used to accelerate the Company,s strategic ... and marketing. "Square 1 believes in supporting ...
... Pharma, Inc. is pleased to announce that it has ... its lead drug for the treatment of stroke and ... A Phase 1, Open-Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Single ... of Oral and Intravenous Administration of Methamphetamine Hydrochloride in ...
Cached Biology Technology:MRIGlobal Appoints Richard A. Winegar, Ph.D., as Principal Advisor for Science 2Avisena Closes $2.5 Million of Debt Capital By Square 1 Bank 2Sinapis Pharma Completes Phase I Trial 2
(Date:7/14/2014)... oxygen control insect body size? What influence does genetics have ... of Current Opinion in Insect Science launched ... Current Opinion in Insect Science is the latest ... review journal that aims to provide specialists with a unique ... published in the field of insect science. First articles published ...
(Date:7/14/2014)... with roots in the local environment manage much better ... from foreign environments. , A world without bees ... Denmark alone an additional 600 million to 1 billion ... done by bees making honey and pollinating a wide ... , Unfortunately, bees all over the world are under ...
(Date:7/14/2014)... genes that improved the harvesting of sunlight, a new ... genomes reveals. The findings could help current efforts to ... a ,genetic snapshot, of maize as it existed 10 ... of its genome a ,whole genome duplication, event. ... ,copied, genes to cope with the pressures of domestication, ...
Breaking Biology News(10 mins):Best for bees to be stay-at-homes 2A-maize-ing double life of a genome 2
... gases and increase production at the same time has been ... Industries' (DPI) Wollongbar Agricultural Institute. , Trials of agrichar - ... and the environment - have doubled and, in one case, ... tonnes per hectare. , Agrichar is a black ...
... tiger now occupies a mere 7 percent of its historic ... has declined by 41 percent over the past decade, according ... BioScience. Growing trade in folk medicines made from tiger parts ... believed to be the chief reason for the losses. The ...
... long been clear that smoking causes cancer, but new research ... who smokes. , Canadian researchers have demonstrated in ... of sperm cells, alterations that could potentially be inherited by ... June 1 issue of Cancer Research, a journal of the ...
Cached Biology News:Soils offer new hope as carbon sink 2Soils offer new hope as carbon sink 3Threats to wild tigers growing 2Cigarette smoke alters DNA in sperm, genetic damage could pass to offspring 2
Mouse monoclonal antibody raised against a partial recombinant EBI3. NCBI Entrez Gene ID = EBI3...
... AS-2055 and AS-2057 are fully automatic sample ... possible level of precision. Sampling flexibility is ... (microplate) for,laboratory automation and combinatorial chemistry. Also ... or the standard rack for 50 2,ml ...
...
... Covance's BCIP/NBT Chromogen system ... Tetrazolium] chromogen in a single ... reacts in the presence of ... purple staining with minimal background ...
Biology Products: